Search results
Found 59781 matches for
Results from an insight review commissioned by the Wellcome Trust, highlights what is currently known about the benefits and risks of using selective serotonin reuptake inhibitors (SSRIs) for the treatment of depression and anxiety in young people.
Willem Kuyken
F - L
PhD, DClinPsy Willem Kuyken - Sir John Ritblat Family Foundation Professor of Mindfulness and Psychological Science
Jennifer Rendell
M - R
MA(Oxon), DPhil, MBPsS Jennifer Rendell - Research Fellow & Deputy Director of Graduate Studies
Elizabeth Tunbridge
S - Z
B.Sc. M.Sc. D.Phil. Elizabeth Tunbridge - Director of Translational Neuroscience, Boehringer Ingelheim
Philip Burnet
A - E
BSc(Hons), MSc, PhD Philip Burnet - Associate Professor and Director of Graduate Studies
Catherine Harmer
F - L
DPhil, MA, DipLATHE Catherine Harmer - Associate Head of Department (People and Culture), Professor of Cognitive Neuroscience
Rebecca Park
M - R
BSc MB BCh FRCPsych PhD Rebecca Park - Associate Professor and Honorary Consultant Psychiatrist
Ksenija Yeeles
S - Z
DPhil, BSc (Hons) Ksenija Yeeles - Associate Research Group Leader, Research Member of Common Room Kellogg College
John Gallacher
F - L
PhD AFBPsS CPsychol FFPH John Gallacher - Professor of Cognitive Health; Director, Dementias Platform UK; Director, BrainWaves study of adolescent wellbeing and mental health
Jane Fossey
F - L
BSc MSc DPsych CPsychol AFBPS Jane Fossey - Associate Director of Psychological Services Oxford Health NHS FT